• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    80.54 Up 4.46(5.86%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development60,368  56,750  50,149  34,965  
    Selling General and Administrative7,968  7,475  3,741  6,155  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (68,336) (64,225) (53,890) (41,120)
    Income from Continuing Operations
    Total Other Income/Expenses Net(1,080)3,258  1,406  1,770  
    Earnings Before Interest And Taxes(69,416)(60,967)(52,484)(39,350)
    Interest Expense2,097  2,075  2,604   -  
    Income Before Tax(71,513)(63,042)(55,088)(39,350)
    Income Tax Expense18  102  (181)292  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(71,531)(63,144)(54,907)(39,642)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (71,531) (63,144) (54,907) (39,642)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (71,531) (63,144) (54,907) (39,642)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.